Link to this page
Physician Data Query
Preferred Name | escitalopram oxalate | |
Synonyms |
5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-,(1S)-, ethanedioate(1:1) Lexapro Lu 26-054-0 |
|
Definitions |
The oxalate salt of escitalopram, a pure S-enantiomer of the racemic bicyclic phthalane derivative citalopram, with antidepressant activity. As a selective serotonin reuptake inhibitor (SSRI), escitalopram blocks the reuptake of serotonin by neurons in the central nervous system (CNS), thereby potentiating CNS serotonergic activity. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C47518" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C47518" NCI Thesaurus) |
|
ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000497135 |
|
altLabel |
5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-,(1S)-, ethanedioate(1:1) Lexapro Lu 26-054-0
|
|
CAS Registry |
219861-08-2
|
|
cui |
C1765323 C1170746 C1170371
|
|
DATE FIRST PUBLISHED |
2006-07-25
|
|
definition |
The oxalate salt of escitalopram, a pure S-enantiomer of the racemic bicyclic phthalane derivative citalopram, with antidepressant activity. As a selective serotonin reuptake inhibitor (SSRI), escitalopram blocks the reuptake of serotonin by neurons in the central nervous system (CNS), thereby potentiating CNS serotonergic activity. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C47518" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C47518" NCI Thesaurus)
|
|
LT |
TRD
|
|
NCI ID |
C47518
|
|
notation |
CDR0000497135
|
|
ORIG STY |
Drug/agent
|
|
prefLabel |
escitalopram oxalate
|
|
tui |
T109 T121
|
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |